aluates Reports

$ 0.0

Automative

Global Bortezomib API Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-2I7797

Global and China Bortezomib API Market Insights Forecast to 2027

BUY CHAPTERS

Global Bortezomib API Market Research Report 2025

Code: QYRE-Auto-2I7797

Report

July 2025

Pages:104

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Scion Pharm Taiwan

Farmhispania Group

TAPI (Teva)

Shilpa Medicare Limited

Dr. Reddy’s Laboratories

Gland Chemicals

ICROM

Vinkem Labs

Qilu Pharmaceutial

Chem-Stone(Guangzhou)

Chengdu Aslee Biopharmaceuticals

CoreSyn

Hubei Honch Pharmaceutical

Bortezomib API Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Bortezomib API Market

The global market for Bortezomib API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

It is white solid in appearance, CAS number is 179324-69-7, and the molecular formula is C19H25BN4O4.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bortezomib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bortezomib API.

The Bortezomib API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bortezomib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bortezomib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Bortezomib API Market Report

Report Metric	Details
Report Name	Bortezomib API Market
CAGR	5%
by Type	Purity ≥ 98 % Purity ≥ 99 %
by Application	Injection Other
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Scion Pharm Taiwan, Farmhispania Group, Tapi Teva, Shilpa Medicare Limited, Dr. Reddy's Laboratories, Gland Chemicals, Icrom, Vinkem Labs, Qilu Pharmaceutial, Chem-Stone(Guangzhou), Chengdu Aslee Biopharmaceuticals, Coresyn, Hubei Honch Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bortezomib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Bortezomib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Bortezomib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bortezomib API Market report?

Ans: The main players in the Bortezomib API Market are Scion Pharm Taiwan, Farmhispania Group, Tapi Teva, Shilpa Medicare Limited, Dr. Reddy's Laboratories, Gland Chemicals, Icrom, Vinkem Labs, Qilu Pharmaceutial, Chem-Stone(Guangzhou), Chengdu Aslee Biopharmaceuticals, Coresyn, Hubei Honch Pharmaceutical

What are the Application segmentation covered in the Bortezomib API Market report?

Ans: The Applications covered in the Bortezomib API Market report are Injection, Other

What are the Type segmentation covered in the Bortezomib API Market report?

Ans: The Types covered in the Bortezomib API Market report are Purity ≥ 98 %, Purity ≥ 99 %

1 Bortezomib API Market Overview

1.1 Product Definition

1.2 Bortezomib API by Type

1.2.1 Global Bortezomib API Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Purity ≥ 98 %

1.2.3 Purity ≥ 99 %

1.3 Bortezomib API by Application

1.3.1 Global Bortezomib API Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Injection

1.3.3 Other

1.4 Global Market Growth Prospects

1.4.1 Global Bortezomib API Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Bortezomib API Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Bortezomib API Production Estimates and Forecasts (2020-2031)

1.4.4 Global Bortezomib API Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Bortezomib API Production Market Share by Manufacturers (2020-2025)

2.2 Global Bortezomib API Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Bortezomib API, Industry Ranking, 2023 VS 2024

2.4 Global Bortezomib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Bortezomib API Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Bortezomib API, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Bortezomib API, Product Offered and Application

2.8 Global Key Manufacturers of Bortezomib API, Date of Enter into This Industry

2.9 Bortezomib API Market Competitive Situation and Trends

2.9.1 Bortezomib API Market Concentration Rate

2.9.2 Global 5 and 10 Largest Bortezomib API Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Bortezomib API Production by Region

3.1 Global Bortezomib API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Bortezomib API Production Value by Region (2020-2031)

3.2.1 Global Bortezomib API Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Bortezomib API by Region (2026-2031)

3.3 Global Bortezomib API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Bortezomib API Production Volume by Region (2020-2031)

3.4.1 Global Bortezomib API Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Bortezomib API by Region (2026-2031)

3.5 Global Bortezomib API Market Price Analysis by Region (2020-2025)

3.6 Global Bortezomib API Production and Value, Year-over-Year Growth

3.6.1 North America Bortezomib API Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Bortezomib API Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Bortezomib API Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Bortezomib API Production Value Estimates and Forecasts (2020-2031)

4 Bortezomib API Consumption by Region

4.1 Global Bortezomib API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Bortezomib API Consumption by Region (2020-2031)

4.2.1 Global Bortezomib API Consumption by Region (2020-2025)

4.2.2 Global Bortezomib API Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Bortezomib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Bortezomib API Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Bortezomib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Bortezomib API Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Bortezomib API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Bortezomib API Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Bortezomib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Bortezomib API Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Bortezomib API Production by Type (2020-2031)

5.1.1 Global Bortezomib API Production by Type (2020-2025)

5.1.2 Global Bortezomib API Production by Type (2026-2031)

5.1.3 Global Bortezomib API Production Market Share by Type (2020-2031)

5.2 Global Bortezomib API Production Value by Type (2020-2031)

5.2.1 Global Bortezomib API Production Value by Type (2020-2025)

5.2.2 Global Bortezomib API Production Value by Type (2026-2031)

5.2.3 Global Bortezomib API Production Value Market Share by Type (2020-2031)

5.3 Global Bortezomib API Price by Type (2020-2031)

6 Segment by Application

6.1 Global Bortezomib API Production by Application (2020-2031)

6.1.1 Global Bortezomib API Production by Application (2020-2025)

6.1.2 Global Bortezomib API Production by Application (2026-2031)

6.1.3 Global Bortezomib API Production Market Share by Application (2020-2031)

6.2 Global Bortezomib API Production Value by Application (2020-2031)

6.2.1 Global Bortezomib API Production Value by Application (2020-2025)

6.2.2 Global Bortezomib API Production Value by Application (2026-2031)

6.2.3 Global Bortezomib API Production Value Market Share by Application (2020-2031)

6.3 Global Bortezomib API Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Scion Pharm Taiwan

7.1.1 Scion Pharm Taiwan Bortezomib API Company Information

7.1.2 Scion Pharm Taiwan Bortezomib API Product Portfolio

7.1.3 Scion Pharm Taiwan Bortezomib API Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Scion Pharm Taiwan Main Business and Markets Served

7.1.5 Scion Pharm Taiwan Recent Developments/Updates

7.2 Farmhispania Group

7.2.1 Farmhispania Group Bortezomib API Company Information

7.2.2 Farmhispania Group Bortezomib API Product Portfolio

7.2.3 Farmhispania Group Bortezomib API Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Farmhispania Group Main Business and Markets Served

7.2.5 Farmhispania Group Recent Developments/Updates

7.3 Tapi Teva

7.3.1 Tapi Teva Bortezomib API Company Information

7.3.2 Tapi Teva Bortezomib API Product Portfolio

7.3.3 Tapi Teva Bortezomib API Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Tapi Teva Main Business and Markets Served

7.3.5 Tapi Teva Recent Developments/Updates

7.4 Shilpa Medicare Limited

7.4.1 Shilpa Medicare Limited Bortezomib API Company Information

7.4.2 Shilpa Medicare Limited Bortezomib API Product Portfolio

7.4.3 Shilpa Medicare Limited Bortezomib API Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Shilpa Medicare Limited Main Business and Markets Served

7.4.5 Shilpa Medicare Limited Recent Developments/Updates

7.5 Dr. Reddy's Laboratories

7.5.1 Dr. Reddy's Laboratories Bortezomib API Company Information

7.5.2 Dr. Reddy's Laboratories Bortezomib API Product Portfolio

7.5.3 Dr. Reddy's Laboratories Bortezomib API Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Dr. Reddy's Laboratories Main Business and Markets Served

7.5.5 Dr. Reddy's Laboratories Recent Developments/Updates

7.6 Gland Chemicals

7.6.1 Gland Chemicals Bortezomib API Company Information

7.6.2 Gland Chemicals Bortezomib API Product Portfolio

7.6.3 Gland Chemicals Bortezomib API Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Gland Chemicals Main Business and Markets Served

7.6.5 Gland Chemicals Recent Developments/Updates

7.7 Icrom

7.7.1 Icrom Bortezomib API Company Information

7.7.2 Icrom Bortezomib API Product Portfolio

7.7.3 Icrom Bortezomib API Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Icrom Main Business and Markets Served

7.7.5 Icrom Recent Developments/Updates

7.8 Vinkem Labs

7.8.1 Vinkem Labs Bortezomib API Company Information

7.8.2 Vinkem Labs Bortezomib API Product Portfolio

7.8.3 Vinkem Labs Bortezomib API Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Vinkem Labs Main Business and Markets Served

7.8.5 Vinkem Labs Recent Developments/Updates

7.9 Qilu Pharmaceutial

7.9.1 Qilu Pharmaceutial Bortezomib API Company Information

7.9.2 Qilu Pharmaceutial Bortezomib API Product Portfolio

7.9.3 Qilu Pharmaceutial Bortezomib API Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Qilu Pharmaceutial Main Business and Markets Served

7.9.5 Qilu Pharmaceutial Recent Developments/Updates

7.10 Chem-Stone(Guangzhou)

7.10.1 Chem-Stone(Guangzhou) Bortezomib API Company Information

7.10.2 Chem-Stone(Guangzhou) Bortezomib API Product Portfolio

7.10.3 Chem-Stone(Guangzhou) Bortezomib API Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Chem-Stone(Guangzhou) Main Business and Markets Served

7.10.5 Chem-Stone(Guangzhou) Recent Developments/Updates

7.11 Chengdu Aslee Biopharmaceuticals

7.11.1 Chengdu Aslee Biopharmaceuticals Bortezomib API Company Information

7.11.2 Chengdu Aslee Biopharmaceuticals Bortezomib API Product Portfolio

7.11.3 Chengdu Aslee Biopharmaceuticals Bortezomib API Production, Value, Price and Gross Margin (2020-2025)

7.11.4 Chengdu Aslee Biopharmaceuticals Main Business and Markets Served

7.11.5 Chengdu Aslee Biopharmaceuticals Recent Developments/Updates

7.12 Coresyn

7.12.1 Coresyn Bortezomib API Company Information

7.12.2 Coresyn Bortezomib API Product Portfolio

7.12.3 Coresyn Bortezomib API Production, Value, Price and Gross Margin (2020-2025)

7.12.4 Coresyn Main Business and Markets Served

7.12.5 Coresyn Recent Developments/Updates

7.13 Hubei Honch Pharmaceutical

7.13.1 Hubei Honch Pharmaceutical Bortezomib API Company Information

7.13.2 Hubei Honch Pharmaceutical Bortezomib API Product Portfolio

7.13.3 Hubei Honch Pharmaceutical Bortezomib API Production, Value, Price and Gross Margin (2020-2025)

7.13.4 Hubei Honch Pharmaceutical Main Business and Markets Served

7.13.5 Hubei Honch Pharmaceutical Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Bortezomib API Industry Chain Analysis

8.2 Bortezomib API Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Bortezomib API Production Mode & Process Analysis

8.4 Bortezomib API Sales and Marketing

8.4.1 Bortezomib API Sales Channels

8.4.2 Bortezomib API Distributors

8.5 Bortezomib API Customer Analysis

9 Bortezomib API Market Dynamics

9.1 Bortezomib API Industry Trends

9.2 Bortezomib API Market Drivers

9.3 Bortezomib API Market Challenges

9.4 Bortezomib API Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Scion Pharm Taiwan

Farmhispania Group

TAPI (Teva)

Shilpa Medicare Limited

Dr. Reddy’s Laboratories

Gland Chemicals

ICROM

Vinkem Labs

Qilu Pharmaceutial

Chem-Stone(Guangzhou)

Chengdu Aslee Biopharmaceuticals

CoreSyn

Hubei Honch Pharmaceutical

List of Tables

Table 1. Global Bortezomib API Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Bortezomib API Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Bortezomib API Production Capacity (MT) by Manufacturers in 2024

Table 4. Global Bortezomib API Production by Manufacturers (2020-2025) & (MT)

Table 5. Global Bortezomib API Production Market Share by Manufacturers (2020-2025)

Table 6. Global Bortezomib API Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Bortezomib API Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Bortezomib API, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Bortezomib API as of 2024)

Table 10. Global Market Bortezomib API Average Price by Manufacturers (USD/Kg) & (2020-2025)

Table 11. Global Key Manufacturers of Bortezomib API, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Bortezomib API, Product Offered and Application

Table 13. Global Key Manufacturers of Bortezomib API, Date of Enter into This Industry

Table 14. Global Bortezomib API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Bortezomib API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Bortezomib API Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Bortezomib API Production Value Market Share by Region (2020-2025)

Table 19. Global Bortezomib API Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Bortezomib API Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Bortezomib API Production Comparison by Region: 2020 VS 2024 VS 2031 (MT)

Table 22. Global Bortezomib API Production (MT) by Region (2020-2025)

Table 23. Global Bortezomib API Production Market Share by Region (2020-2025)

Table 24. Global Bortezomib API Production (MT) Forecast by Region (2026-2031)

Table 25. Global Bortezomib API Production Market Share Forecast by Region (2026-2031)

Table 26. Global Bortezomib API Market Average Price (USD/Kg) by Region (2020-2025)

Table 27. Global Bortezomib API Market Average Price (USD/Kg) by Region (2026-2031)

Table 28. Global Bortezomib API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (MT)

Table 29. Global Bortezomib API Consumption by Region (2020-2025) & (MT)

Table 30. Global Bortezomib API Consumption Market Share by Region (2020-2025)

Table 31. Global Bortezomib API Forecasted Consumption by Region (2026-2031) & (MT)

Table 32. Global Bortezomib API Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Bortezomib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)

Table 34. North America Bortezomib API Consumption by Country (2020-2025) & (MT)

Table 35. North America Bortezomib API Consumption by Country (2026-2031) & (MT)

Table 36. Europe Bortezomib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)

Table 37. Europe Bortezomib API Consumption by Country (2020-2025) & (MT)

Table 38. Europe Bortezomib API Consumption by Country (2026-2031) & (MT)

Table 39. Asia Pacific Bortezomib API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (MT)

Table 40. Asia Pacific Bortezomib API Consumption by Region (2020-2025) & (MT)

Table 41. Asia Pacific Bortezomib API Consumption by Region (2026-2031) & (MT)

Table 42. Latin America, Middle East & Africa Bortezomib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)

Table 43. Latin America, Middle East & Africa Bortezomib API Consumption by Country (2020-2025) & (MT)

Table 44. Latin America, Middle East & Africa Bortezomib API Consumption by Country (2026-2031) & (MT)

Table 45. Global Bortezomib API Production (MT) by Type (2020-2025)

Table 46. Global Bortezomib API Production (MT) by Type (2026-2031)

Table 47. Global Bortezomib API Production Market Share by Type (2020-2025)

Table 48. Global Bortezomib API Production Market Share by Type (2026-2031)

Table 49. Global Bortezomib API Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Bortezomib API Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Bortezomib API Production Value Market Share by Type (2020-2025)

Table 52. Global Bortezomib API Production Value Market Share by Type (2026-2031)

Table 53. Global Bortezomib API Price (USD/Kg) by Type (2020-2025)

Table 54. Global Bortezomib API Price (USD/Kg) by Type (2026-2031)

Table 55. Global Bortezomib API Production (MT) by Application (2020-2025)

Table 56. Global Bortezomib API Production (MT) by Application (2026-2031)

Table 57. Global Bortezomib API Production Market Share by Application (2020-2025)

Table 58. Global Bortezomib API Production Market Share by Application (2026-2031)

Table 59. Global Bortezomib API Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Bortezomib API Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Bortezomib API Production Value Market Share by Application (2020-2025)

Table 62. Global Bortezomib API Production Value Market Share by Application (2026-2031)

Table 63. Global Bortezomib API Price (USD/Kg) by Application (2020-2025)

Table 64. Global Bortezomib API Price (USD/Kg) by Application (2026-2031)

Table 65. Scion Pharm Taiwan Bortezomib API Company Information

Table 66. Scion Pharm Taiwan Bortezomib API Specification and Application

Table 67. Scion Pharm Taiwan Bortezomib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 68. Scion Pharm Taiwan Main Business and Markets Served

Table 69. Scion Pharm Taiwan Recent Developments/Updates

Table 70. Farmhispania Group Bortezomib API Company Information

Table 71. Farmhispania Group Bortezomib API Specification and Application

Table 72. Farmhispania Group Bortezomib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 73. Farmhispania Group Main Business and Markets Served

Table 74. Farmhispania Group Recent Developments/Updates

Table 75. Tapi Teva Bortezomib API Company Information

Table 76. Tapi Teva Bortezomib API Specification and Application

Table 77. Tapi Teva Bortezomib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 78. Tapi Teva Main Business and Markets Served

Table 79. Tapi Teva Recent Developments/Updates

Table 80. Shilpa Medicare Limited Bortezomib API Company Information

Table 81. Shilpa Medicare Limited Bortezomib API Specification and Application

Table 82. Shilpa Medicare Limited Bortezomib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 83. Shilpa Medicare Limited Main Business and Markets Served

Table 84. Shilpa Medicare Limited Recent Developments/Updates

Table 85. Dr. Reddy's Laboratories Bortezomib API Company Information

Table 86. Dr. Reddy's Laboratories Bortezomib API Specification and Application

Table 87. Dr. Reddy's Laboratories Bortezomib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 88. Dr. Reddy's Laboratories Main Business and Markets Served

Table 89. Dr. Reddy's Laboratories Recent Developments/Updates

Table 90. Gland Chemicals Bortezomib API Company Information

Table 91. Gland Chemicals Bortezomib API Specification and Application

Table 92. Gland Chemicals Bortezomib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 93. Gland Chemicals Main Business and Markets Served

Table 94. Gland Chemicals Recent Developments/Updates

Table 95. Icrom Bortezomib API Company Information

Table 96. Icrom Bortezomib API Specification and Application

Table 97. Icrom Bortezomib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 98. Icrom Main Business and Markets Served

Table 99. Icrom Recent Developments/Updates

Table 100. Vinkem Labs Bortezomib API Company Information

Table 101. Vinkem Labs Bortezomib API Specification and Application

Table 102. Vinkem Labs Bortezomib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 103. Vinkem Labs Main Business and Markets Served

Table 104. Vinkem Labs Recent Developments/Updates

Table 105. Qilu Pharmaceutial Bortezomib API Company Information

Table 106. Qilu Pharmaceutial Bortezomib API Specification and Application

Table 107. Qilu Pharmaceutial Bortezomib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 108. Qilu Pharmaceutial Main Business and Markets Served

Table 109. Qilu Pharmaceutial Recent Developments/Updates

Table 110. Chem-Stone(Guangzhou) Bortezomib API Company Information

Table 111. Chem-Stone(Guangzhou) Bortezomib API Specification and Application

Table 112. Chem-Stone(Guangzhou) Bortezomib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 113. Chem-Stone(Guangzhou) Main Business and Markets Served

Table 114. Chem-Stone(Guangzhou) Recent Developments/Updates

Table 115. Chengdu Aslee Biopharmaceuticals Bortezomib API Company Information

Table 116. Chengdu Aslee Biopharmaceuticals Bortezomib API Specification and Application

Table 117. Chengdu Aslee Biopharmaceuticals Bortezomib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 118. Chengdu Aslee Biopharmaceuticals Main Business and Markets Served

Table 119. Chengdu Aslee Biopharmaceuticals Recent Developments/Updates

Table 120. Coresyn Bortezomib API Company Information

Table 121. Coresyn Bortezomib API Specification and Application

Table 122. Coresyn Bortezomib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 123. Coresyn Main Business and Markets Served

Table 124. Coresyn Recent Developments/Updates

Table 125. Hubei Honch Pharmaceutical Bortezomib API Company Information

Table 126. Hubei Honch Pharmaceutical Bortezomib API Specification and Application

Table 127. Hubei Honch Pharmaceutical Bortezomib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 128. Hubei Honch Pharmaceutical Main Business and Markets Served

Table 129. Hubei Honch Pharmaceutical Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Bortezomib API Distributors List

Table 133. Bortezomib API Customers List

Table 134. Bortezomib API Market Trends

Table 135. Bortezomib API Market Drivers

Table 136. Bortezomib API Market Challenges

Table 137. Bortezomib API Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Bortezomib API

Figure 2. Global Bortezomib API Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Bortezomib API Market Share by Type: 2024 VS 2031

Figure 4. Purity ≥ 98 % Product Picture

Figure 5. Purity ≥ 99 % Product Picture

Figure 6. Global Bortezomib API Market Value by Application, (US$ Million) & (2020-2031)

Figure 7. Global Bortezomib API Market Share by Application: 2024 VS 2031

Figure 8. Injection

Figure 9. Other

Figure 10. Global Bortezomib API Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Bortezomib API Production Value (US$ Million) & (2020-2031)

Figure 12. Global Bortezomib API Production Capacity (MT) & (2020-2031)

Figure 13. Global Bortezomib API Production (MT) & (2020-2031)

Figure 14. Global Bortezomib API Average Price (USD/Kg) & (2020-2031)

Figure 15. Bortezomib API Report Years Considered

Figure 16. Bortezomib API Production Share by Manufacturers in 2024

Figure 17. Global Bortezomib API Production Value Share by Manufacturers (2024)

Figure 18. Bortezomib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. The Global 5 and 10 Largest Players: Market Share by Bortezomib API Revenue in 2024

Figure 20. Global Bortezomib API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 21. Global Bortezomib API Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 22. Global Bortezomib API Production Comparison by Region: 2020 VS 2024 VS 2031 (MT)

Figure 23. Global Bortezomib API Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 24. North America Bortezomib API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 25. Europe Bortezomib API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 26. China Bortezomib API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. Japan Bortezomib API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. Global Bortezomib API Consumption by Region: 2020 VS 2024 VS 2031 (MT)

Figure 29. Global Bortezomib API Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 30. North America Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 31. North America Bortezomib API Consumption Market Share by Country (2020-2031)

Figure 32. U.S. Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 33. Canada Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 34. Europe Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 35. Europe Bortezomib API Consumption Market Share by Country (2020-2031)

Figure 36. Germany Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 37. France Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 38. U.K. Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 39. Italy Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 40. Russia Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 41. Asia Pacific Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 42. Asia Pacific Bortezomib API Consumption Market Share by Region (2020-2031)

Figure 43. China Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 44. Japan Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 45. South Korea Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 46. China Taiwan Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 47. Southeast Asia Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 48. India Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 49. Latin America, Middle East & Africa Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 50. Latin America, Middle East & Africa Bortezomib API Consumption Market Share by Country (2020-2031)

Figure 51. Mexico Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 52. Brazil Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 53. Turkey Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 54. GCC Countries Bortezomib API Consumption and Growth Rate (2020-2031) & (MT)

Figure 55. Global Production Market Share of Bortezomib API by Type (2020-2031)

Figure 56. Global Production Value Market Share of Bortezomib API by Type (2020-2031)

Figure 57. Global Bortezomib API Price (USD/Kg) by Type (2020-2031)

Figure 58. Global Production Market Share of Bortezomib API by Application (2020-2031)

Figure 59. Global Production Value Market Share of Bortezomib API by Application (2020-2031)

Figure 60. Global Bortezomib API Price (USD/Kg) by Application (2020-2031)

Figure 61. Bortezomib API Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gefitinib API Market Research Report 2024

Global Abiraterone Acetate API Market Research Report 2024

Global Oxaliplatin API Market Research Report 2024

Global Hydroxyurea API Market Research Report 2024

Global Cisplatin API Market Research Report 2024

Global Capecitabine API Market Research Report 2024

Global Platinum based Anticancer APIs Market Research Report 2024

Global Carboplatin API Market Research Report 2024

Global Docetaxel Anhydrous API Market Research Report 2024

Global Cefepime API Market Research Report 2024

Bosutinib API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Erlotinib Hydrochloride API Market Research Report 2024

Global Ceftezole Sodium API Market Research Report 2024

Arbidol API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Irinotecan Hydrochloride API Market Research Report 2024

Global Imidazolinone API Market Research Report 2025

Global Proteasome Inhibitor Drug Market Research Report 2024

Global Cefprozil API Market Research Report 2024

Global Ceftizoxime Sodium API Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions